Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : A US National Health Care System? -- Ignore unavailable to you. Want to Upgrade?

To: Peter Dierks who wrote (3216)	12/12/2007 10:28:13 AM
From: TimF	Read Replies (1) \| Respond to of 42652

Obviously pharmaceutical companies can choose not to sell into markets that are not willing to pay a fair price for their goods. They can. But the countries can force compulsory licensing on them. EU forces Big Pharma to license drugs to ‘countries in need’ legalit.itproportal.com Brazil Moves on compulsory license after failed talks with drug company Published in SUNS # 6242 dated 1 May 2007 Geneva, 30 Apr (Sangeeta Shashikant) -- The Brazilian government has declared its intention to issue a compulsory licence for the AIDS drug Efavirenz, if the patent holder, the drug multinational company Merck Sharpe and Dome (MSD), does not adequately reduce its price. The Ministry of Health revealed that its decision to issue a compulsory license ordinance came after talks with the company failed to lower prices of the AIDS drug... twnside.org.sg Examples of Health-Related Compulsory Licenses cptech.org